- Home
- YY vs OMCL Comparison
YY vs OMCL Comparison
Compare YY & OMCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YY
- OMCL
- Stock Information
- Founded
- YY 2005
- OMCL 1992
- Country
- YY Singapore
- OMCL United States
- Employees
- YY N/A
- OMCL N/A
- Industry
- YY EDP Services
- OMCL Computer Manufacturing
- Sector
- YY Technology
- OMCL Technology
- Exchange
- YY Nasdaq
- OMCL Nasdaq
- Market Cap
- YY 2.2B
- OMCL 2.0B
- IPO Year
- YY 2012
- OMCL 2001
- Fundamental
- Price
- YY $39.78
- OMCL $44.32
- Analyst Decision
- YY Hold
- OMCL Buy
- Analyst Count
- YY 3
- OMCL 6
- Target Price
- YY $35.00
- OMCL $52.00
- AVG Volume (30 Days)
- YY 697.4K
- OMCL 513.6K
- Earning Date
- YY 11-26-2024
- OMCL 02-06-2025
- Dividend Yield
- YY 2.01%
- OMCL N/A
- EPS Growth
- YY N/A
- OMCL N/A
- EPS
- YY 3.11
- OMCL N/A
- Revenue
- YY $2,258,181,000.00
- OMCL $1,064,205,999.00
- Revenue This Year
- YY $0.62
- OMCL N/A
- Revenue Next Year
- YY $1.84
- OMCL $5.24
- P/E Ratio
- YY $13.44
- OMCL N/A
- Revenue Growth
- YY N/A
- OMCL N/A
- 52 Week Low
- YY $27.88
- OMCL $25.12
- 52 Week High
- YY $42.88
- OMCL $55.75
- Technical
- Relative Strength Index (RSI)
- YY 51.17
- OMCL 46.46
- Support Level
- YY $40.27
- OMCL $42.80
- Resistance Level
- YY $42.88
- OMCL $44.69
- Average True Range (ATR)
- YY 1.79
- OMCL 1.47
- MACD
- YY -0.07
- OMCL -0.12
- Stochastic Oscillator
- YY 60.61
- OMCL 34.62
About YY JOYY Inc.
JOYY Inc is a global technology company offering comprehensive innovation capabilities. The company enables users to interact with others in real time. The group is actively exploring and expanding its global commerce Software-as-a-Service and solutions business. JOYY emphasizes technological innovation and is recognized in the industry for its significant number of patent applications and licenses.
About OMCL Omnicell Inc. ($0.001 par value)
Omnicell Inc provides automation and business analytics software for healthcare providers. It helps its customers to define and deliver cost-effective medication management that is designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks, and to drive improved clinical, operational, and financial outcomes across all care settings. Omnicell generates the vast majority of its revenue in the United States.